PubRank

Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27474734)

Published in Cancer Res on July 29, 2016

Authors

Jonathan M Pitt1, Marie Vétizou2, Nadine Waldschmitt3, Guido Kroemer4, Mathias Chamaillard3, Ivo Gomperts Boneca5, Laurence Zitvogel6

Author Affiliations

1: Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France. INSERM Unit U1015, Villejuif, France. Université Paris Sud, Université Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. laurence.zitvogel@orange.fr jonathan.pitt@gustaveroussy.fr.
2: Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France. INSERM Unit U1015, Villejuif, France. Université Paris Sud, Université Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France.
3: Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France.
4: Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France. INSERM Unit U1015, Villejuif, France. INSERM, U1138, Paris, France. Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France. Center of Clinical Investigations CICBT1428, Gustave Roussy Cancer Campus, 94805, Villejuif, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Department of Women's and Children's Health, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
5: Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France.
6: Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France. INSERM Unit U1015, Villejuif, France. Université Paris Sud, Université Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Center of Clinical Investigations CICBT1428, Gustave Roussy Cancer Campus, 94805, Villejuif, France. laurence.zitvogel@orange.fr jonathan.pitt@gustaveroussy.fr.

Articles citing this ↘

Considerations for successful cancer immunotherapy in aged hosts. Clin Exp Immunol (2016) 0.81

Regulation of inflammation by microbiota interactions with the host. Nat Immunol (2017) 0.75

Looking beyond the cancer cell for effective drug combinations. Genome Med (2016) 0.75

Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications. Biores Open Access (2016) 0.75

Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. J Immunol (2017) 0.75

Articles by these authors ⇆

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (2015) 3.12